IFC Medical Becomes Chameleon Scientific
IFC Medical announced that its Board of Directors has approved a new name for the company, Chameleon Scientific. ”We chose Chameleon Scientific to reinforce our focus on creating high performance surfaces for medical devices. The name Chameleon serves as a metaphor for our abilities to change the surfaces of inserted and implanted medical devices using the principles of atomic and molecular physics.” said CTO Dan Storey.
Chameleon Scientific develops specialty surfaces for medical device manufacturers to provide unique performance to manufacturers of medical devices. The company’s surfaces deliver tunable antimicrobial performance; deliver attachment of bone, gum and other cells; prevent cell attachment, provide drug delivery without degradable polymers; delivery peptides, proteins, and growth factors; provide radiopacity and broad range of other high-performance capabilities.
IFC Medical’s First Issued Patent
IFC Medical announced the issuance of its first patent for an entirely new method of surface modification. The fast track patent application was filed in January of this year and awarded in just under seven months. US Patent #7,250,195. Molecular Plasma Deposition of Colloidal Materials.
Chameleon Technical Papers
Chameleon, in conjunction with its academic research partners, has had the following papers published or presented:
"Greater osteoblast long-term functions on ionic plasma deposited nanostructured orthopedic implant coatings"
Journal of Biomedical Materials Research, 17 Dec 2007
"Nanostructured metal coatings on polymers increase osteoblast attachment"
International Journal of Nanomedicine 2007:2(3)
"Decreased Fibroblast and Increased Osteoblast Functions on Ionic Plasma Deposited Nanostructured Ti Coatings"
Nanoscale Research Letters (2007) 2:385–390, 4 July 2007
"Low Temperature IPD AgO Bacterial Static / Bactericidal Coatings for Medical Applications"
ASM Materials & Processes for Medical Devices Conference, November 16, 2005
|
